Skip to main content

Enabling technology to make ultrasensitive cancer recurrence scalable and accessible

Our vision, our mission, and the value we bring to the MRD ecosystem.

Our vision & mission

Our vision
A world where cancer recurrence is caught before it takes hold.
Our mission
To make ultrasensitive MRD testing scalable and accessible beyond the elite health system of the world.
Value proposition

Accessible and scalable ultrasensitive MRD technology

Access

  • Expand access

    Bring ultrasensitive MRD detection beyond a limited number of elite health systems.

  • Enable serial monitoring

    Make repeated testing after curative treatment more economically viable.

Operational efficiency

  • Protect margins

    Strengthen test economics amid reimbursement pressure.

  • Increase throughput

    Process more samples with fewer sequencing reads required per test.

Want to learn more about our science?

See how our proprietary rare variant enrichment technology makes ultra-deep MRD monitoring accessible and scalable.